C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen

被引:86
作者
Lasser, G
Guchhait, P
Ellsworth, JL
Sheppard, P
Lewis, K
Bishop, P
Cruz, MA
Lopez, JA
Fruebis, J
机构
[1] Zymogenet Inc, Seattle, WA 98102 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2005-04-1425
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CTRP-1 is a novel member of the Clq-TNF-related protein family containing family characteristic collagen and TNF-like domains and shows marked expression in vascular wall tissue. We observed that recombinant human CTRP-1 specifically bound to fibrillar collagen and blocked collagen-induced platelet aggregation. CTRP-1 completely or partially prevented VWF and GPVI-Fc4 binding to collagen, respectively. However, GPVI-Fc4 failed to compete for the binding of CTRP-1 to collagen. CTRP-1 had no effects on alpha(2)beta(1) integrin I-domain binding to collagen. Using whole human blood under flow at low and high shear rates, CTRP-1 prevented platelets from accumulating on a collagen-coated surface but had no effects on '' platelet-rolling '' on a surface coated with VWF. These data suggest that CTRP-1 prevents collagen-induced platelet aggregation by specific blockade of VWF binding to collagen. By using the Folts vascular injury model in nonhuman primates (Macaca fascicularis), we were able to demonstrate that CTRP-1 can prevent platelet thrombosis in vivo. This effect was achieved in the absence of changes in activated-clotting time (ACT) and template cut bleeding times, suggesting that CTRP-1 has promising antiplatelet thrombotic activity and most likely acts by pacifying the thrombogenic site of vascular injury.
引用
收藏
页码:423 / 430
页数:8
相关论文
共 38 条
[1]   PLATELET-AGGREGATION MONITORED IN A 96-WELL MICROPLATE READER IS USEFUL FOR EVALUATION OF PLATELET AGONISTS AND ANTAGONISTS [J].
BEDNAR, B ;
CONDRA, C ;
GOULD, RJ ;
CONNOLLY, TM .
THROMBOSIS RESEARCH, 1995, 77 (05) :453-463
[2]   The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [J].
Berg, AH ;
Combs, TP ;
Du, XL ;
Brownlee, M ;
Scherer, PE .
NATURE MEDICINE, 2001, 7 (08) :947-953
[3]   Von Willebrand factor present in fibrillar collagen enhances platelet adhesion to collagen and collagen-induced platelet aggregation [J].
Bernardo, A ;
Bergeron, AL ;
Sun, CW ;
Guchhait, P ;
Cruz, MA ;
López, JA ;
Dong, JF .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (04) :660-669
[4]  
Clemetson KJ, 1999, HAEMOSTASIS, V29, P16
[5]  
Clemetson KJ, 2001, THROMB HAEMOSTASIS, V86, P189
[6]  
CRUZ MA, 1995, J BIOL CHEM, V270, P19668
[7]   LOCALIZATION OF VONWILLEBRAND-FACTOR BINDING DOMAINS TO ENDOTHELIAL EXTRACELLULAR-MATRIX AND TO TYPE-VI COLLAGEN [J].
DENIS, C ;
BARUCH, D ;
KIELTY, CM ;
AJZENBERG, N ;
CHRISTOPHE, O ;
MEYER, D .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (03) :398-406
[8]   Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions [J].
Dong, JF ;
Berndt, MC ;
Schade, A ;
McIntire, LV ;
Andrews, RK ;
López, JA .
BLOOD, 2001, 97 (01) :162-168
[9]   The role of collagen in thrombosis and hemostasis [J].
Farndale, RW ;
Sixma, JJ ;
Barnes, MJ ;
De Groot, PG .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (04) :561-573
[10]  
FOLTS J, 1991, CIRCULATION, V83, P3